Nicholas Augustinos, Director at DEXCOM INC (DXCM), sold 12,580 shares at $81.69 ($1.0M) on 2025-06-13, disclosed to the SEC on 2025-06-17.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.69 | 2,618 | $214K | 20.6% |
| 2 | $81.69 | 2,618 | $214K | 20.6% |
| 3 | $82.80 | 3,672 | $304K | 29.4% |
| 4 | $82.80 | 3,672 | $304K | 29.4% |
| Total | $82.34 avg | 12,580 | $1.0M | 100% |
| Filing → |
| DXCM | SELL | 2021-11-02 | $1.5M | — | Filing → |
| DXCM | SELL | 2021-06-07 | $592K | — | Filing → |
| DXCM | SELL | 2021-02-17 | $1.5M | — | Filing → |